Musso Alan A — SEC Form 4 filings

SEC reporting owner CIK 1295830. 7 Form 4 filings on record with FilingPulse; latest filed 2026-02-04.

Transaction summary — filings shown

Covers all 7 filings on record, filed 2024-01-19 to 2026-02-04. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Fulcrum Therapeutics, Inc. (FULC)Chief Financial Officer44
Rein Therapeutics, Inc. (RNTX)Director33

Form 4 filings — Musso Alan A

FiledFormIssuerReported transactionsSource
2026-02-044Fulcrum Therapeutics, Inc. (FULC)Grant/award (A): 170,000 (derivative) @ $0EDGAR
2025-07-234Rein Therapeutics, Inc. (RNTX)Grant/award (A): 17,500 (derivative) @ $0EDGAR
2025-01-284Fulcrum Therapeutics, Inc. (FULC)Grant/award (A): 285,000 (derivative) @ $0EDGAR
2024-12-064Aileron Therapeutics, Inc. (ALRN)Grant/award (A): 35,000 (derivative) @ $0EDGAR
2024-08-224Aileron Therapeutics, Inc. (ALRN)Grant/award (A): 2,725 (derivative) @ $0EDGAR
2024-01-304Fulcrum Therapeutics, Inc. (FULC)Grant/award (A): 100,000 (derivative) @ $0EDGAR
2024-01-194Fulcrum Therapeutics, Inc. (FULC)Grant/award (A): 61,822 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1295830 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →